Justice Department Investigating Novation; BD Faces Whistleblower Lawsuit
This article was originally published in The Gray Sheet
Executive Summary
BD maintains it is not the target of a U.S. Department of Justice criminal investigation of Novation, despite being subpoenaed to provide evidence in the case against the group purchasing organization
You may also be interested in...
Medtronic whistleblowers
Firm receives copy of second civil qui tam complaint Sept. 2 on "allegations under the False Claims Act" similar to charges a September 2003 whistleblower brought against its Sofamor Danek spinal division, according to Medtronic's recent 110-Q filing. The Department of Justice is investigating "certain payments and other services provided to physicians by Medtronic" that may have been "improper inducements under the federal anti-kickback statute." The case is under seal at Memphis federal court. In its quarterly report filed with SEC Aug. 13, BD revealed it has been cited by a qui tam complaint, also on the False Claims Act (2"The Gray Sheet" Aug. 30, 2004, p. 22)...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”